The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
News|Articles|August 1, 2003
Pyoderma Gangrenosum
Pyoderma Gangrenosum belongs in the differential diagnosis of lower extremity vasculitis-like ulcerating lesions.
Advertisement
This rare condition of unknown cause belongs in the differential diagnosis of lower extremity vasculitis-like ulcerating lesions. It usually occurs in association with rheumatoid arthritis, inflammatory bowel disease, Wegener granulomatosis, chronic active hepatitis, and Behçet disease.1
The lesion, which is usually singular, has an irregular, undermined, and raised border. It forms a painful ulcer, typically on the lower extremities or buttocks.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
Advertisement
Advertisement
Trending on Patient Care Online
1
CagriSema Cuts Weight Up to 27% Across Menopause Stages: TMS 2026
2
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
3
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
4
Menopause Hormone Therapy Gaps Raise Questions for Primary Care
5